Thesis icon

Thesis

Biomarkers for Parkinson’s disease and Alzheimer’s disease

Abstract:

Alzheimer’s Disease (AD) and Parkinson’s Disease (PD) represent the two most prevalent neurodegenerative diseases in the world, affecting 30 million and 5 million people, respectively. As populations age, the global burden of AD and PD will increase, resulting in significant societal and economic implications. By 2050, it is estimated that 1 in 85 people will have AD. Biomarkers, surrogate indicators of physiological or pathophysiological states, can be used to guide the diagnosis of disea...

Expand abstract

Actions


Access Document


Authors


More by this author
Division:
MSD
Department:
Psychiatry
Role:
Author

Contributors

Role:
Supervisor
More from this funder
Name:
Rhodes Trust
Funding agency for:
Liu, B
Type of award:
DPhil
Level of award:
Doctoral
Awarding institution:
University of Oxford
UUID:
uuid:66fb10d2-607a-4295-86bf-073f72348a35
Deposit date:
2019-02-25

Terms of use


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP